PMWC 2012 Speakers:
Brian Druker M.D., OHSU
Amir Dan Rubin President & CEO Stanford Hospital and Clinics
Naomi Aronson Ph.D., Executive Direction Blue Cross Blue Shield
Mara Aspinall President Ventana Medical Systems
Joffre B. Baker Ph.D., Chief Scientific Officer Genomic Health
Barrett Bready, President & Chief Executive Officer NABsys
Alexis Borisy Chairman of the Board and Co-Founder Foundation Medicine
Pierre Cassigneul President & Chief Executive Officer XDx Cardio
William Dalton Ph.D., M.D., President, CEO & Director Moffitt Cancer Center
Brett Davis Senior Director Oracle Health Sciences
Laura Esserman M.D., MBA, Director Carol Franc Buck Breast Care Center & Professor UCSF
Steven Finkbeiner M.D., Ph.D., Associate Director Gladstone Institute of Neurological Disease
Felix Frueh Ph.D., VP and R&D Medco Health Solutions, Inc.
David Galas Sr., Ph.D., VP Institute for Systems Biology
Evian Gordon BSc, Ph.D., MBBCH, Chairman & CEO Brain Resource
Pat Groody Ph.D., Divisional VP, R&D Abbott Diagnostics
Marc Hellerstein M.D., Ph.D., Co-Founder and Chairman of Scientific Advisory Board KineMed
James Heywood Co-Founder & Chairman PatientsLikeMe
Andrea Klemes DO, FACE Medical Director MDVIP
Jon Kobashigawa M.D., Associate Director Cedars-Sinai Heart Institute
Walter Koch Ph.D., VP & Head of Global Research Roche Molecular Systems
Jean-Pierre Kocher Ph.D., Bioinformatics Core Director, Health Sciences Research Mayo Clinic
C. Ola Landgren M.D., Senior Investigator National Cancer Institute
David H. Ledbetter Ph.D., FACMG, Executive VP & Chief Scientific Officer Geisinger Health Systems
Lawrence Lesko Ph.D., Professor College of Pharmaceutics, University of Florida
Ronald Levy M.D., Ph.D., Chief Division of Oncology Stanford Medical School
Elizabeth Mansfield Ph.D., Director of Personalized Medicine FDA
Stephen Montgomery Ph.D., Asst. Professor, Stanford University School of Medicine
David Parkinson M.D., CEO Nodality
Scott Patterson Ph.D., Executive Director Amgen Molecular Sciences
Michael J. Pellini M.D., President & CEO Foundation Medicine
Michael Phelps Ph.D., Director of Institute for Molecular Medicine at School of Medicine UCLA
Catherine Polizzi Ph.D., Partner Morrison & Foerster LLP
Bruce Quinn M.D., Senior Health Policy Specialist Foley Hoag
Ron Ribitzky M.D., CEO R&D Ribitzky
Stefan Roever, CEO Genia Technologies, Inc.
Michael Shuster Ph.D., IP Partner & Life Sciences Group Co-Chair Fenwick & West LLP
Ralph Snyderman M.D., Chancellor Emeritus Duke University
Sharon Terry, President & CEO Genetic Alliance
Chris Toumazou Ph.D., Biomedical Engineering Imperial College London, CEO DNA Electronics
Peter Yu M.D., Director of Cancer Research Palo Alto Medical Foundation
Steven Bartz Ph.D., Director of Worldwide Licensing Merck & Co., Inc.
Paul Beresford Ph.D., VP of Business Development and Strategic Marketing Biodesix
Flavia Borellini Ph.D., Life Cycle Leader for Zelboraf Genentech
James S. Burns, President & CEO AssureRx
Atul Butte M.D., Ph.D., Director, Center for Pediatric Bioinformatics Lucile Packard Children's Hospital
Ashley Dombkowski Ph.D., Chief Business Officer 23andMe
Jill Hagenkord M.D., Chief Medical Officer Complete Genomics
Mary Haak-Frendscho Ph.D., President & CSO Takeda Pharmaceuticals San Francisco
Ann Kapoun Ph.D., VP of Translational Medicine OncoMed Pharmaceuticals
Andrew Kurtz Ph.D., Program Director, SBIR Development Center National Cancer Institute
Jessica Melin Ph.D., MBA, Senior Manager, Business Developmet & Sales, Biosciences Sony DADC
Robert Michel, Editor in Chief The Dark Report
C. Douglas Monroe, RPh, MS, FCSHP Project Manager Bio & Pharma Tech Kaiser Permanente
Louise Perkins Ph.D., CSO Multiple Myeloma Research Foundation
Stephen Quake Ph.D., Professor of Bioengineering Stanford University
Hakan Sakul Ph.D., Sr. Director & Global Head of Diagnostics & Oncology Pfizer
Lidia Sambucetti Ph.D., Sr. Director, Center for Cancer Research SRI International
Andrew Schorr, Founder Patient Power
Elizabeth Worthey Ph.D., Assistant Professor Medical College of Wisconsin
Gerald McDougall, Partner PricewaterhouseCoopers
Andre de Fusco, CEO Cynvenio Biosystems
Mark Blumenkranz M.D., CEO Digisight Network
Robert Gould Ph.D., President & CEO Epizyme
Ken Fang M.D., CMO Integrated Diagnostics
David Fineman Ph.D., President & CEO Kinemed
Michael Paul Ph.D., CEO Lineagen
Zachary Antovich, Founder & CEO Linkage Biosciences
Paul Rhodes Ph.D., CEO Metabolomx
Peter Leigh, CEO Microsonic Systems
Ilya Kupershmidt Ph.D., Co-Founder & VP of Products NextBio Enterprise
Gil Blander Ph.D., Founder & President & CEO Segterra
Richard Goold Ph.D., CEO Station X
Peter Payne, CBO TCLand Expression
Calvin Harley Ph.D., President & CSO Telome Health
Robert Booth Ph.D., CEO Virobay
Alan Nelson Ph.D., CEO & Founder Visiongate
Jim Kean, CEO WellnessFX |
